使用海洋Serratia rubidaea菌株改善生物加工条件,以生产大量素
Ricardo F S Pereira1,2, Carla C C R de Carvalho1,2
1Department of Bioengineering, iBB-Institute for Bioengineering and Biosciences, Instituto Superior Técnico, Universidade de Lisboa, Av. Rovisco Pais, 1049-001 Lisboa, Portugal.
Marine drugs
|April 26, 2024
概括
这项研究优化了使用Serratia菌株的生物工艺来生产奇异,使摇瓶增加了13倍,并在生物反应器中实现了惊人的293.1mg/L. 这些进展突出了神奇的进步.
科学领域:
- 微生物学 微生物学
- 生物技术是生物技术.
- 自然产品 化学 化学
背景情况:
- 作为一种天然色素和制药剂,Prodigiosin具有显著的潜力.
- 高效的生物工艺对于其大规模生产至关重要.
- 海洋细菌,如Serratia菌株,是有价值的微生物化合物的来源.
研究的目的:
- 为了优化生物工艺,以提高神奇素的生产.
- 调查介质成分,环境因素和扩大规模对奇异产量的影响.
- 为了评估不同海洋Serratia物种中的 prodigiosin 产量.
主要方法:
- 优化Serratia rubidaea的生长媒介组成.
- 调查最佳温度,光线和氧气要求.
- 使用氧气质量转移系数 (kLa) 将生物工艺从摇瓶扩展到生物反应器.
主要成果:
- 在摇瓶中,prodigiosin产量增加了13倍 (19.7 mg/L).
- 在优化的条件下,Serratia marcescens产生了15.8毫克/升的奇异.
- 扩展到生物反应器的结果是293.1 mg/L的奇氨酸度,每种生物质产量的产量增加了8倍.
结论:
- 优化的生物过程显著提高了海洋Serratia菌株的prodigiosin生产.
- 该研究表明,工业制造业的扩大战略取得了成功.
- 微生物生物工艺的进一步发展可以释放天然颜料和制药剂的潜力.
关键词:
塞拉蒂亚 (Serratia marcescensens) 是一种的植物.塞拉蒂亚·鲁比迪亚 (Serratia rubidaea) 是一个植物.生物反应器的生物反应器在这里,KLa kLa.中等工程技术 工程技术更多相关视频
06:24Generic Protocol for Optimization of Heterologous Protein Production Using Automated Microbioreactor Technology
Published on: December 15, 2017
10.0K
09:49Prospecting Microbial Strains for Bioremediation and Probiotics Development for Metaorganism Research and Preservation
Published on: October 31, 2019
22.3K
相关概念视频
Bioreactor Controls-III
71
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
71
Scale-Up Processes
119
The scale-up of microbial fermentation processes is essential in industrial biotechnology, allowing the transition from laboratory-scale experiments to commercial-scale production while aiming to maintain product yield and quality. This process requires meticulous adjustment of equipment design, process parameters, and contamination control strategies to accommodate increasing culture volumes.At the laboratory scale, cultures are typically maintained in 1 to 10-liter glass or autoclavable...
119
Upstream Processing
103
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
103
Production of Antibiotics
285
Penicillin, one of the earliest and most widely used antibiotics, is produced industrially by the filamentous fungus Penicillium chrysogenum. Large stirred-tank bioreactors ranging from tens to hundreds of thousands of liters maintain tightly controlled temperature, pH, and dissolved oxygen conditions to support fungal metabolism and maximize antibiotic yield. Penicillin is a secondary metabolite, synthesized primarily during the stationary growth phase, which requires a carefully managed...
285
Production of Pharmaceuticals
100
Industrial insulin production uses genetically engineered E. coli expressing a proinsulin gene controlled by a tryptophan promoter and containing a methionine linker for later cleavage. The cells also carry ampicillin resistance for selective growth. Seed cultures are stored at −80 °C and production begins by thawing a small amount to inoculate starter cultures, which are progressively scaled to a 50,000-L bioreactor. In the bioreactor, E. coli grow in nutrient-rich media under...
100
